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Purpose: Percutaneous epidural neuroplasty (PEN) is a minimally invasive treat-
ment. The efficacy of PEN has been relatively well investigated; however, the rela-
tionship between the clinical effectiveness of PEN and the severity of spinal canal 
stenosis by disc material has not yet been established. The purpose of this study 
was to compare clinical outcomes of PEN according to the dural sac cross-section-
al area in single level disc disease. Materials and Methods: This study included 
363 patients with back pain from single level disc disease with and without radicu-
lopathy. Patients were categorized into groups according to spinal canal compro-
mise by disc material: Category 1, less or more than 50%; and Category 2, three 
subgroups with lesser than a third, between a third and two thirds, and more than 
two thirds. Clinical outcomes were assessed according to the Visual Analog Scale 
(VAS) score for back pain and leg pain and Odom’s criteria at 1, 3, 6, 12, and 24 
months after treatment. Results: The demographic data showed no difference be-
tween groups according to spinal canal compromise by disc material except age 
(older age correlated with more spinal canal compromise). The dural sac cross-
sectional area did not correlate with the VAS scores for back and leg pain after 
PEN in single level disc disease in Groups 1 and 2. Odom’s criteria after PEN 
were also not different according to dural sac cross-sectional area by disc material. 
Conclusion: PEN is an effective procedure in treating single level lumbar disc her-
niation without affecting dural sac cross-sectional area.
Key Words:   Lower back pain, lumbar disc disease, percutaneous epidural neuro-
plasty, percutaneous adhesiolysis, dural sac cross-sectional area
INTRODUCTION
Percutaneous epidural neuroplasty (PEN) is a minimally invasive therapy in which 
a flexible and steerable catheter is inserted directly into a region affected by a her-
niated disc or scar tissue that is thought to be compromising a nerve root. PEN has 
been used to treat intractable chronic pain that is nonresponsive to more conserva-
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LDH. To the best of our knowledge, no clinical observa-
tions of the efficacy of PEN for treating LDH have been 
conducted, nor have any clinical comparisons been made 
according to dural sac cross-sectional area with more than 
12 months of follow-up.
MATERIALS AND METHODS
After gaining Institutional Review Board approval (IRB 
No: 3190493AN01-201310-HR-006), patients meeting the 
following criteria were enrolled in this retrospective obser-
vational study: 1) diagnosed with single level LDH, 2) sin-
gle level LDH was classified from L3/4 to L5/S1 (inclu-
sive), 3) underwent PEN treatment at a single hospital from 
February 2010 to March 2011, and 4) underwent follow-up 
study for more than 12 months. Single level LDH diagnosis 
was based on MRI findings, clinical symptoms, and a neu-
rological examination. To measure the dural sac cross-sec-
tional area (mm2), MRI scans were analyzed and manually 
marginated using an imaging program (PACSPLUS PPW, 
Medical Standard, Seongnam, Korea). The cross-sectional 
area was separated into total spinal canal area and dissemi-
nated into the dural spinal canal area, as presented in Fig. 1. 
Patients were classified into groups according to their dural 
sac cross-sectional area, including 50% canal compromise 
(Category 1-1, less than 50%; Category 1-2, more than 50%) 
and 33.3% to 66.7% canal compromise (Category 2-1, less 
than 33.3%; Category 2-2, between 33.3% and 66.7%; Cate-
gory 2-3, more than 66.7%). All patients had suffered from 
chronic lower back or leg pain for at least 1 month; further-
more, conservative treatments such as anti-inflammatory 
medications, physical therapy, and conventional epidural 
steroid injections had failed to provide acceptable pain re-
lief. Additional inclusion criteria for patients were: 1) older 
than 18 years of age, 2) diagnosis of single level LDH with 
radicular pain or radiculopathy symptoms refractory to con-
servative treatments, 3) able to provide written consent to 
participate in a clinical trial, and 4) suspected presence of ad-
hesion. Patients with multi-level LDH, lumbar stenosis, spi-
nal cord lesions, hyaluronic acid-sensitive side effects, and 
uncontrolled diabetes, as well as those who had undergone 
previous lumbar operations, were excluded. 
The Visual Analogue Scale (VAS; score range: 0 to 10, 
with 0 reflecting no pain) for back pain (VAS back) and leg 
pain (VAS leg), as well as Odom’s criteria, which rate out-
comes as excellent, good, fair, or poor, were used to evalu-
tive management techniques and has shown good clinical 
efficacy.1-3 Furthermore, PEN has been shown to have cer-
tain advantages over physical therapy and caudal epidural 
steroid injections for the treatment of chronic lower back 
and leg pain; namely, PEN potentially reduces the number 
of adhesions and the amount of fibrous tissue, which can 
prevent the spread of injected medications around the af-
fected neural tissues.4,5 Thus, PEN is usually performed in 
patients for whom conservative treatments and convention-
al injections have failed. 
Lumbar disc herniation (LDH) is recorded in a large 
number of cases of lumbar nerve root compression includ-
ing those involving young patients,6-8 and fibrous and scar 
tissue around nerve roots may cause continuous neuropath-
ic pain. Moreover, adhesions formed after spinal surgery 
may also result in chronic inflammation and nerve root irri-
tation. For patients without significant neurological defi-
ciencies, conservative treatments of lower back pain are 
likely sufficient for optimal short and long term outcomes. 
Therefore, recent studies have attempted to determine the 
efficacy of PEN for treating disc disease. In one such study, 
disc disease was classified into different types, including 
bulging, protrusion, extrusion, and sequestration, or by Pfir-
rmann disc degeneration grade according to magnetic reso-
nance imaging (MRI) results.9 Interestingly, the efficacy of 
PEN according to the type of lumbar disc disease was not 
determined, as the authors purported that the type of lumbar 
disc disease is not significantly correlated with the severity 
of disc disease. Thus, we conducted this study to determine 
whether the clinical outcome of PEN is affected by the pa-
tient’s dural sac cross-sectional area and also to evaluate the 
effectiveness and safety of PEN for treating single level 
Fig. 1. Image of a typical dural sac cross-sectional area, showing the total 
spinal canal area (white dashed line), canal area compromised by disc ma-
terial (gray dashed line), and neural structures (dark gray dashed line).
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For statistical analysis, Student’s t-test, ANOVA, and the 
chi-square test were conducted to determine the significance 
of radiological and clinical outcomes. All statistical analyses 
were performed using SPSS software (SPSS Inc., Chicago, 
IL, USA), with statistical significance defined as p<0.05.
RESULTS
 
In total, 363 patients were enrolled in this study, each with 
more than 12 months follow-up; moreover, 102 of these pa-
tients were followed for 24 months. Target levels were con-
secutive in 26 cases for L3/4, in 229 cases for L4/5, and in 
108 cases for L5/S1. Among these patients, 277 cases 
(76.3%) were injected with single nerve root blocks prior to 
adhesiolysis. The demographic data of the groups are sum-
marized in Table 1 and Fig. 3. The average age at treatment 
was 46.9 years old, and 48.8% of patients were male. 
Group 1 patients included Category 1-1 (degree of spinal 
canal compromise less than 50%), containing 157 patients 
with 12 months follow-up and 43 patients with 24 months 
follow-up, and Category 1-2 (degree of spinal canal com-
promise more than 50%), containing 206 patients with 12 
months follow-up and 59 patients with 24 months follow-
up. Group 2 patients included Category 2-1 (degree of spi-
nal canal compromise less than 33.3%), containing 75 pa-
tients with 12 months follow-up and 21 patients with 24 
months follow-up; Category 2-2 (degree of spinal canal 
compromise between 33.3% and 66.7%), containing 154 
ate the clinical effectiveness of PEN. Its effectiveness was 
measured in terms of pain reduction and functional im-
provement before treatment (as a control), and then at 1, 3, 
6, 12, and 24 months after PEN treatment. Each patient rat-
ed the average severities of his/her symptoms over the week 
preceding his/her visit. Successful pain relief was described 
as a 50% or more reduction in the patient’s VAS score; 
good or excellent results by Odom’s criteria were consid-
ered to reflect favorable outcomes. 
PEN was performed with a fluoroscopy machine in a ster-
ile operating room with monitoring equipment for blood 
pressure, pulse rate, and pulse oximetry. The fluoroscopy 
machine was adjusted over the lumbosacral area such that a 
caudal approach could be used for both the anteroposterior 
and lateral views. After appropriate positioning of the fluo-
roscopy machine, the needle insertion area around the sacral 
hiatus was determined and then injected with local anesthet-
ic. An RK needle (Epimed International Inc., Johnstown, 
NY, USA) was introduced into the caudal epidural space un-
der fluoroscopic guidance, and a lumbar epidurogram was 
performed using approximately 5 mL of a non-iodinated 
contrast agent (IOBRIX, ACCUZEN, Seoul, Korea). Filling 
defects were identified by examining the contrast flow pat-
tern (Fig. 2). The placement of the needle was confirmed to 
be neither intravascular nor subarachnoid; if such misposi-
tioning occurred, the needle was repositioned. After per-
forming diagnostic epidurography, a Racz catheter was ad-
vanced through the RK needle to either the area of the 
filling defect or the site of pathology, as determined by 
MRI. Adhesiolysis was then carried out, and the needle was 
finally positioned in either the epidural space or into the lat-
eral and ventral epidural space. Following satisfactory posi-
tioning of the catheter, at least 3 mL of contrast agent was 
injected. In the absence of subarachnoid, intravascular, or 
other extra-epidural filling, and when the epidural and tar-
geted regions were satisfactorily filled, 6 mL of 0.2% preser-
vative-free ropivacaine, containing 1500 units of hyaluroni-
dase and 4 mL of 40% triamcinolone acetate, was injected. 
One hour after this procedure, 6 mL of 8% sodium chloride 
solution was infused over 30 minutes in the recovery room, 
under monitoring. The intravenous line and epidural catheter 
were removed, and the patient was discharged if all parame-
ters were satisfactory. The first follow-up examination was 
performed 2 weeks after the procedure. During these two 
weeks, all participants received non-steroidal anti-inflamma-
tory drugs  and muscle relaxants to reduce procedure-related 
discomfort. 
Fig. 2. Epidurography pattern of percutaneous epidural neuroplasty at the 
level of L4/5.
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1 and 2 exhibited similar sex ratios, manifestations of symp-
toms, preprocedural symptom durations, and VAS scores 
for back and leg pain.
Clinical assessment results are summarized in Figs. 4 and 
5. The mean VAS scores of back and leg pain, respectively, 
were: 6.8 and 4.1 preoperatively, 1.9 and 1.2 after 1 month, 
2.3 and 1.4 after 3 months, 2.2 and 1.4 after 6 months, 2.9 
and 1.5 after 12 months, and 3.2 and 1.9 after 24 months 
(all p<0.001 compared to preoperative status, with 363 cas-
es followed for 12 months and 102 of these followed for 24 
patients with 12 months follow-up and 47 patients with 24 
months follow-up; and Category 2-3 (degree of spinal ca-
nal compromise more than 66.7%), containing 134 patients 
with 12 months follow-up and 34 patients with 24 months 
follow-up. In each group, old age tended to correlate with a 
higher degree of spinal canal compromise (mean age 42.8 
years old in Category 1-1 and 48.3 years old in Category 
1-2, p<0.001; mean age 43.5 years old in Category 2-1, 
44.0 years old in Category 2-2, and 49.5 years old in Cate-
gory 2-3, p=0.795, 0.002, and 0.001, respectively). Groups 
Fig. 3. Flowchart of patient stratification and follow-up after percutaneous epidural neuroplasty (PEN) due to lumbar disc herniation (LDH).
Total PEN procedure patients due to LDH
363 patients
363 patients
Group 1-1:
canal compromise
<50%
Group 1-2:
canal compromise
>50%
Group 2-1:
canal compromise
<33.3%
Group 2-2:
canal compromise
33.3–66.7%
Group 2-3:
canal compromise
>66.7%
157 patients 206 patients 75 patients 154 patients 134 patients
Complete 12 months follow-up after PEN procedure
Complete 24 months follow-up after PEN procedure
157 patients 206 patients 75 patients 154 patients 134 patients
43 patients 59 patients 21 patients 47 patients 34 patients
363 patients
Spinal canal cross-sectional area
Table 1. Demographic Data of Patients Who Underwent Percutaneous Epidural Neuroplasty According to Their Dural Sac 
Cross-Sectional Areas
Group
G1-1 G1-2 p value G2-1 G2-2 G2-3 p value
<50% ≥50%
G1-1 vs. 
G1-2
<33.3% 33.3‒66.7% >66.7%
 G2-1 vs. G2-2, 
 G2-1 vs. G2-3, 
G2-2 vs. G2-3
Age (yrs) 42.8±13.3 48.3±13.3 <0.001 43.5±13.0 44.0±13.7 49.5±13.0 0.795, 0.002, 0.001
Sex (percentage male)  48 49   0.907 43 52 49 0.189, 0.419, 0.562
    Back pain 99 99   0.729 99 100 99 0.152, 0.926, 0.129
    Leg pain 68 68   0.969 72 66 69 0.332, 0.615, 0.582
    Numbness 51 56   0.441 52 50 61 0.778, 0.198, 0.057
    Weakness   1   1   0.729   1   1   1 0.604, 0.678, 0.922
Symptom duration  
  (months) 25.4±34.8 22.8±35.7   0.486 27.6±37.6 22.8±35.4 23.2±34.0 0.356, 0.390, 0.937
    PreVAS (back) 6.9±1.1 6.8±1.3   0.619 6.8±1.0 6.9±1.1 6.8±1.4 0.523, 0.873, 0.395
    PreVAS (leg) 6.9±1.1 4.2±2.1   0.493 3.9±2.3 4.0±2.2 4.3±1.9 0.654, 0.099, 0.153
No. cases 157 206 - 75 154 134 -
VAS, Visual Analog Scale.
Category 1-1, with less than 50%; Category 1-2, with more than 50%; Category 2-1, with less than 33.3%; Category 2-2, between 33.3% and 66.7%; and 
Category 2-3, with more than 66.7%.
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12- or 24-month follow-up examinations). No statistically 
significant differences in dural sac cross-sectional areas 
were observed between any categories or groups (Table 1).
DISCUSSION
In the present study, patients were categorized according to 
the extent of dural sac cross-sectional area compromise; 
clinical outcomes after PEN treatment did not correlate with 
the degree of compromise. Some studies have reported a 
correlation between the degree of spinal canal compromise 
and the extent of clinical symptoms; however, all of these 
studies focused exclusively on lumbar spinal stenosis.10-13 
In contrast, the degree of radiographic lumbar spinal steno-
sis was found to have no relationship with either the extent of 
clinical symptoms or the Oswestry Disability Index percent-
age score.11,12 Regarding a possible correlation between spi-
nal canal dimensions and the efficacy of epidural steroid in-
jections in spinal stenosis, spinal canal dimensions have 
months). Within Group 1 (Fig. 4), the mean VAS scores of 
back and leg pain, respectively, improved from 6.9 and 4.0 
(preoperatively) to 2.8 and 1.4 (12 months after PEN treat-
ment) and 2.8 and 1.9 (24 months after PEN treatment) in 
Category 1-1. Likewise, VAS scores improved from 6.8 
and 4.2 (preoperatively) to 2.9 and 1.6 (12 months after 
PEN treatment) and 3.6 and 1.9 (24 months after PEN 
treatment) in Category 1-2 (all p values<0.001 between 
preoperative scores and scores at either 12- or 24-month 
follow-up examinations). Within Group 2 (Fig. 5), the 
mean VAS scores of back and leg pain, respectively, im-
proved from 6.8 and 3.9 (preoperatively) to 2.8 and 1.3 (12 
months after PEN treatment) and 2.6 and 2.3 (24 months 
after PEN treatment) in Category 2-1; from 6.8 and 4.3 
(preoperatively) to 3.0 and 1.7 (12 months after PEN treat-
ment) and 3.4 and 1.4 (24 months after PEN treatment) in 
Category 2-2; and from 6.8 and 4.3 (preoperatively) to 3.0 
and 1.7 (12 months after PEN treatment) and 3.4 and 1.4 
(24 months after PEN treatment) in Category 2-3 (all p val-
ues<0.001 between preoperative scores and scores at either 
Fig. 4. Comparison of VAS scores according to the degree of spinal canal compromise (less or more than 50%) at 0, 1, 3, 6, 12, and 24 months after treatment. 
No statistically significant differences (p<0.05) were observed between the groups during the follow-up periods. VAS, Visual Analog Scale.
Fig. 5. Comparison of VAS scores according to the degree of spinal canal compromise (less than 33.3%, between 33.3 to 66.7%, and more than 66.7%) at 0, 1, 
3, 6, 12, and 24 months after treatment. No statistically significant differences (p<0.05) were observed between the groups during the follow-up periods. VAS, 
Visual Analog Scale.
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also hypothesized that extrusion and sequestration would 
be worse predictors of a favorable PEN outcome. In per-
forming PEN for patients with single level LDH, we ob-
tained favorable results. This study indicates that PEN is a 
potentially suitable treatment for patients with single level 
LDH who do not respond to conservative treatment, there-
by negating the need for lumbar surgery.
In conclusion, PEN is an effective procedure for treating 
single level lumbar disc herniation, without affecting the 
dural sac cross-sectional area.
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